Vasculitis Pregnancy Registry

Description

The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.

Conditions

Vasculitis, Behcet's Disease, CNS Vasculitis, Cryoglobulinemic Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Granulomatosis With Polyangiitis (GPA), Wegener's Granulomatosis, IgA Vasculitis, Henoch-Schoenlein Purpura (HSP), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Takayasu Arteritis (TAK), Urticarial Vasculitis, Systemic Vasculitis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.

The Vasculitis Pregnancy Registry (V-PREG)

Vasculitis Pregnancy Registry

Condition
Vasculitis
Intervention / Treatment

-

Contacts and Locations

Tampa

University of South Florida Data Management and Coordinating Center, Tampa, Florida, United States, 33612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Women 18 years of age or older with one of the following diseases may take part in the study:
  • * Behçet's disease;
  • * Central nervous system (CNS) vasculitis;
  • * Cryoglobulinemic vasculitis (Cryoglobulinemia);
  • * Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
  • * Giant Cell (Temporal) Arteritis (GCA);
  • * Granulomatosis with polyangiitis (also called Wegener's);
  • * IgA vasculitis (Henoch-Schoenlein purpura);
  • * Microscopic polyangiitis (MPA);
  • * Polyarteritis nodosa (PAN);
  • * Takayasu's arteritis (TAK);
  • * Urticarial vasculitis;
  • * Other/Suspected Diagnosis.
  • 2. Women must be pregnant (self-report) at the time of enrollment into the registry.
  • 1. Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
  • 2. Unable to provide consent.

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Megan Clowse, MD, MPH, STUDY_CHAIR, Duke University

Peter A Merkel, MD, MPH, STUDY_CHAIR, University of Pennsylvania

Study Record Dates

2026-12